Selected research
Industry Research
Genomics & Sequencing Automation Systems Industry Research Report 2026
Market perspective
The global Genomics & Sequencing Automation Systems market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Genomics & Sequencing Automation Systems market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Genomics & Sequencing Automation Systems market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Genomics & Sequencing Automation Systems market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Genomics & Sequencing Automation Systems include Agilent Technologies, Revvity, Roche Diagnostics, QIAGEN, Hamilton Company, Tecan, Becton Dickinson, Eppendorf and MGI Tech, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Genomics & Sequencing Automation Systems market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Genomics & Sequencing Automation Systems.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Genomics & Sequencing Automation Systems Market by Company
Agilent Technologies
Revvity
Roche Diagnostics
QIAGEN
Hamilton Company
Tecan
Becton Dickinson
Eppendorf
MGI Tech
BGI Genomics
Autobio Diagnostics
Haier Biomedical
DAAN Gene
Illumina
Thermo Fisher Scientific
Danaher
Genomics & Sequencing Automation Systems Segment by Type
Automated Liquid Handling Systems
Automated Nucleic Acid Extraction Systems
NGS Library Preparation Automation Systems
Robotic Sample Processing Workstations
Integrated Genomics Automation Platforms
Sequencing Workflow Automation Systems
Genomics & Sequencing Automation Systems Segment by Application
Pharmaceutical and Biotechnology Companies
Clinical Diagnostic Laboratories
Academic and Research Institutes
Contract Research Organizations (CROs)
Government and Public Health Laboratories
Population Genomics Centers
Genomics & Sequencing Automation Systems Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genomics & Sequencing Automation Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genomics & Sequencing Automation Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genomics & Sequencing Automation Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Genomics & Sequencing Automation Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Automated Liquid Handling Systems
- Automated Nucleic Acid Extraction Systems
- NGS Library Preparation Automation Systems
- Robotic Sample Processing Workstations
- Integrated Genomics Automation Platforms
- Sequencing Workflow Automation Systems
Applications
- Pharmaceutical and Biotechnology Companies
- Clinical Diagnostic Laboratories
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Government and Public Health Laboratories
- Population Genomics Centers
Companies covered
- Agilent Technologies
- Revvity
- Roche Diagnostics
- QIAGEN
- Hamilton Company
- Tecan
- Becton Dickinson
- Eppendorf
- MGI Tech
- BGI Genomics
- Autobio Diagnostics
- Haier Biomedical
- DAAN Gene
- Illumina
- Thermo Fisher Scientific
- Danaher
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Genomics & Sequencing Automation Systems by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Automated Liquid Handling Systems
- 2.2.3 Automated Nucleic Acid Extraction Systems
- 2.2.4 NGS Library Preparation Automation Systems
- 2.2.5 Robotic Sample Processing Workstations
- 2.2.6 Integrated Genomics Automation Platforms
- 2.2.7 Sequencing Workflow Automation Systems
- 2.3 Genomics & Sequencing Automation Systems by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical and Biotechnology Companies
- 2.3.3 Clinical Diagnostic Laboratories
- 2.3.4 Academic and Research Institutes
- 2.3.5 Contract Research Organizations (CROs)
- 2.3.6 Government and Public Health Laboratories
- 2.3.7 Population Genomics Centers
- 2.4 Assumptions and Limitations
3 Genomics & Sequencing Automation Systems Breakdown Data by Type
- 3.1 Global Genomics & Sequencing Automation Systems Historic Market Size by Type (2021-2026)
- 3.2 Global Genomics & Sequencing Automation Systems Forecasted Market Size by Type (2027-2032)
4 Genomics & Sequencing Automation Systems Breakdown Data by Application
- 4.1 Global Genomics & Sequencing Automation Systems Historic Market Size by Application (2021-2026)
- 4.2 Global Genomics & Sequencing Automation Systems Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Genomics & Sequencing Automation Systems Market Perspective (2021-2032)
- 5.2 Global Genomics & Sequencing Automation Systems Growth Trends by Region
- 5.2.1 Global Genomics & Sequencing Automation Systems Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Genomics & Sequencing Automation Systems Historic Market Size by Region (2021-2026)
- 5.2.3 Genomics & Sequencing Automation Systems Forecasted Market Size by Region (2027-2032)
- 5.3 Genomics & Sequencing Automation Systems Market Dynamics
- 5.3.1 Genomics & Sequencing Automation Systems Industry Trends
- 5.3.2 Genomics & Sequencing Automation Systems Market Drivers
- 5.3.3 Genomics & Sequencing Automation Systems Market Challenges
- 5.3.4 Genomics & Sequencing Automation Systems Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Genomics & Sequencing Automation Systems Players by Revenue
- 6.1.1 Global Top Genomics & Sequencing Automation Systems Players by Revenue (2021-2026)
- 6.1.2 Global Genomics & Sequencing Automation Systems Revenue Market Share by Players (2021-2026)
- 6.2 Global Genomics & Sequencing Automation Systems Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Genomics & Sequencing Automation Systems Head Office and Area Served
- 6.4 Global Genomics & Sequencing Automation Systems Players, Product Type & Application
- 6.5 Global Genomics & Sequencing Automation Systems Manufacturers Established Date
- 6.6 Global Genomics & Sequencing Automation Systems Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Genomics & Sequencing Automation Systems Market Size (2021-2032)
- 7.2 North America Genomics & Sequencing Automation Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Genomics & Sequencing Automation Systems Market Size by Country (2021-2026)
- 7.4 North America Genomics & Sequencing Automation Systems Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Genomics & Sequencing Automation Systems Market Size (2021-2032)
- 8.2 Europe Genomics & Sequencing Automation Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Genomics & Sequencing Automation Systems Market Size by Country (2021-2026)
- 8.4 Europe Genomics & Sequencing Automation Systems Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Genomics & Sequencing Automation Systems Market Size (2021-2032)
- 9.2 Asia-Pacific Genomics & Sequencing Automation Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Genomics & Sequencing Automation Systems Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Genomics & Sequencing Automation Systems Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Genomics & Sequencing Automation Systems Market Size (2021-2032)
- 10.2 South America Genomics & Sequencing Automation Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Genomics & Sequencing Automation Systems Market Size by Country (2021-2026)
- 10.4 South America Genomics & Sequencing Automation Systems Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Genomics & Sequencing Automation Systems Market Size (2021-2032)
- 11.2 Middle East & Africa Genomics & Sequencing Automation Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Genomics & Sequencing Automation Systems Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Genomics & Sequencing Automation Systems Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Agilent Technologies
- 12.1.1 Agilent Technologies Company Information
- 12.1.2 Agilent Technologies Business Overview
- 12.1.3 Agilent Technologies Revenue in Genomics & Sequencing Automation Systems Business (2021-2026)
- 12.1.4 Agilent Technologies Genomics & Sequencing Automation Systems Product Portfolio
- 12.1.5 Agilent Technologies Recent Developments
- 12.2 Revvity
- 12.2.1 Revvity Company Information
- 12.2.2 Revvity Business Overview
- 12.2.3 Revvity Revenue in Genomics & Sequencing Automation Systems Business (2021-2026)
- 12.2.4 Revvity Genomics & Sequencing Automation Systems Product Portfolio
- 12.2.5 Revvity Recent Developments
- 12.3 Roche Diagnostics
- 12.3.1 Roche Diagnostics Company Information
- 12.3.2 Roche Diagnostics Business Overview
- 12.3.3 Roche Diagnostics Revenue in Genomics & Sequencing Automation Systems Business (2021-2026)
- 12.3.4 Roche Diagnostics Genomics & Sequencing Automation Systems Product Portfolio
- 12.3.5 Roche Diagnostics Recent Developments
- 12.4 QIAGEN
- 12.4.1 QIAGEN Company Information
- 12.4.2 QIAGEN Business Overview
- 12.4.3 QIAGEN Revenue in Genomics & Sequencing Automation Systems Business (2021-2026)
- 12.4.4 QIAGEN Genomics & Sequencing Automation Systems Product Portfolio
- 12.4.5 QIAGEN Recent Developments
- 12.5 Hamilton Company
- 12.5.1 Hamilton Company Company Information
- 12.5.2 Hamilton Company Business Overview
- 12.5.3 Hamilton Company Revenue in Genomics & Sequencing Automation Systems Business (2021-2026)
- 12.5.4 Hamilton Company Genomics & Sequencing Automation Systems Product Portfolio
- 12.5.5 Hamilton Company Recent Developments
- 12.6 Tecan
- 12.6.1 Tecan Company Information
- 12.6.2 Tecan Business Overview
- 12.6.3 Tecan Revenue in Genomics & Sequencing Automation Systems Business (2021-2026)
- 12.6.4 Tecan Genomics & Sequencing Automation Systems Product Portfolio
- 12.6.5 Tecan Recent Developments
- 12.7 Becton Dickinson
- 12.7.1 Becton Dickinson Company Information
- 12.7.2 Becton Dickinson Business Overview
- 12.7.3 Becton Dickinson Revenue in Genomics & Sequencing Automation Systems Business (2021-2026)
- 12.7.4 Becton Dickinson Genomics & Sequencing Automation Systems Product Portfolio
- 12.7.5 Becton Dickinson Recent Developments
- 12.8 Eppendorf
- 12.8.1 Eppendorf Company Information
- 12.8.2 Eppendorf Business Overview
- 12.8.3 Eppendorf Revenue in Genomics & Sequencing Automation Systems Business (2021-2026)
- 12.8.4 Eppendorf Genomics & Sequencing Automation Systems Product Portfolio
- 12.8.5 Eppendorf Recent Developments
- 12.9 MGI Tech
- 12.9.1 MGI Tech Company Information
- 12.9.2 MGI Tech Business Overview
- 12.9.3 MGI Tech Revenue in Genomics & Sequencing Automation Systems Business (2021-2026)
- 12.9.4 MGI Tech Genomics & Sequencing Automation Systems Product Portfolio
- 12.9.5 MGI Tech Recent Developments
- 12.10 BGI Genomics
- 12.10.1 BGI Genomics Company Information
- 12.10.2 BGI Genomics Business Overview
- 12.10.3 BGI Genomics Revenue in Genomics & Sequencing Automation Systems Business (2021-2026)
- 12.10.4 BGI Genomics Genomics & Sequencing Automation Systems Product Portfolio
- 12.10.5 BGI Genomics Recent Developments
- 12.11 Autobio Diagnostics
- 12.11.1 Autobio Diagnostics Company Information
- 12.11.2 Autobio Diagnostics Business Overview
- 12.11.3 Autobio Diagnostics Revenue in Genomics & Sequencing Automation Systems Business (2021-2026)
- 12.11.4 Autobio Diagnostics Genomics & Sequencing Automation Systems Product Portfolio
- 12.11.5 Autobio Diagnostics Recent Developments
- 12.12 Haier Biomedical
- 12.12.1 Haier Biomedical Company Information
- 12.12.2 Haier Biomedical Business Overview
- 12.12.3 Haier Biomedical Revenue in Genomics & Sequencing Automation Systems Business (2021-2026)
- 12.12.4 Haier Biomedical Genomics & Sequencing Automation Systems Product Portfolio
- 12.12.5 Haier Biomedical Recent Developments
- 12.13 DAAN Gene
- 12.13.1 DAAN Gene Company Information
- 12.13.2 DAAN Gene Business Overview
- 12.13.3 DAAN Gene Revenue in Genomics & Sequencing Automation Systems Business (2021-2026)
- 12.13.4 DAAN Gene Genomics & Sequencing Automation Systems Product Portfolio
- 12.13.5 DAAN Gene Recent Developments
- 12.14 Illumina
- 12.14.1 Illumina Company Information
- 12.14.2 Illumina Business Overview
- 12.14.3 Illumina Revenue in Genomics & Sequencing Automation Systems Business (2021-2026)
- 12.14.4 Illumina Genomics & Sequencing Automation Systems Product Portfolio
- 12.14.5 Illumina Recent Developments
- 12.15 Thermo Fisher Scientific
- 12.15.1 Thermo Fisher Scientific Company Information
- 12.15.2 Thermo Fisher Scientific Business Overview
- 12.15.3 Thermo Fisher Scientific Revenue in Genomics & Sequencing Automation Systems Business (2021-2026)
- 12.15.4 Thermo Fisher Scientific Genomics & Sequencing Automation Systems Product Portfolio
- 12.15.5 Thermo Fisher Scientific Recent Developments
- 12.16 Danaher
- 12.16.1 Danaher Company Information
- 12.16.2 Danaher Business Overview
- 12.16.3 Danaher Revenue in Genomics & Sequencing Automation Systems Business (2021-2026)
- 12.16.4 Danaher Genomics & Sequencing Automation Systems Product Portfolio
- 12.16.5 Danaher Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst